Aerie Pharmaceuticals, Inc. Research and Development in Process
Aerie Pharmaceuticals, Inc. reported Research and Development in Process of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-25.
Discontinued › Notes
us-gaap:ResearchAndDevelopmentInProcess · last filed 2022-02-25
- Aerie Pharmaceuticals, Inc. research and development in process for fiscal 2021 was $0.00.
- Aerie Pharmaceuticals, Inc. research and development in process for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- Aerie Pharmaceuticals, Inc. research and development in process for fiscal 2019 was $10.17M.
- Aerie Pharmaceuticals, Inc. research and development in process for fiscal 2018 was $0.00, a 100.00% decline from fiscal 2017.
| Period end | Research and Development in Process 12 month |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-02-25 |
| 2020-12-31 | $0.00 10-K · filed 2022-02-25 |
| 2019-12-31 | $10.17M 10-K · filed 2022-02-25 |
| 2018-12-31 | $0.00 10-K · filed 2021-02-26 |
| 2017-12-31 | $24.80M 10-K · filed 2020-02-24 |
| 2016-12-31 | $0.00 10-K · filed 2019-03-01 |
| 2015-12-31 | $0.00 10-K · filed 2018-03-01 |